BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3382617)

  • 1. Management of a bleeding aberrant cervical artery following vacuum suction termination. Case report.
    Chordia SK
    Br J Obstet Gynaecol; 1988 Apr; 95(4):411-3. PubMed ID: 3382617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical occlusion due to adhesions following therapeutic abortion: an uncommon sequel to vacuum curettage.
    Fraser IS
    Aust N Z J Obstet Gynaecol; 1984 Nov; 24(4):292-3. PubMed ID: 6598381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine perforation following medical termination of pregnancy by vacuum aspiration.
    Mittal S; Misra SL
    Int J Gynaecol Obstet; 1985 Feb; 23(1):45-50. PubMed ID: 2860032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical hydatidiform mole pregnancy after missed abortion presenting with severe vaginal bleeding: case report and review of the literature.
    Schwentner L; Schmitt W; Bartusek G; Kreienberg R; Herr D
    Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):9-11. PubMed ID: 21272989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
    Fisher PR; Taylor JH
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamicel: a new technique for cervical dilatation before first trimester abortion.
    Nicolaides KH; Welch CC; MacPherson MB; Johnson IR; Filshie GM
    Br J Obstet Gynaecol; 1983 May; 90(5):475-9. PubMed ID: 6849849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of hypan versus gemeprost in cervical preparation prior to second trimester termination of pregnancy.
    Zamblera D; Thilaganathan B; Parsons J
    Br J Obstet Gynaecol; 1994 Jun; 101(6):543-4. PubMed ID: 8018648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoas abscess related to spontaneous abortion, intra-uterine contraceptive device and curettage.
    Scheepers NJ; van Bommel PF; Bleker OP
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):223-4. PubMed ID: 8385862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a balloon dilator before second-trimester abortion by vacuum curettage.
    Stubblefield PG; Frederiksen MC; Berek JS; Gatter MA; Kayman DJ; Borten M
    Am J Obstet Gynecol; 1979 Sep; 135(2):199-201. PubMed ID: 474671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
    Singh K; Fong YF; Prasad RN; Dong F
    Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurement of blood loss in medical termination of pregnancy.
    Gupta I; Majumdar S; Mehta T; Dhall GI; Gupta AN
    Indian J Med Res; 1983 Jul; 78():49-52. PubMed ID: 6642599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic laminaria for cervical dilatation prior to vacuum aspiration in midtrimester pregnancy.
    Brenner WE; Zuspan K
    Am J Obstet Gynecol; 1982 Jun; 143(4):475-7. PubMed ID: 7091212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal cytology and ferning of cervical mucus studies after intra-uterine instillation of solutions for medical termination of pregnancy.
    Nanda U; Maharana S
    J Obstet Gynaecol India; 1978 Dec; 28(6):1106-9. PubMed ID: 12326867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A method of vacuum aspiration in early pregnancy in women with a history of severe gynecologic diseases].
    Khoreva LA
    Akush Ginekol (Mosk); 1992 Feb; (2):37-9. PubMed ID: 1476226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.